Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXQE1A
|
||||
| Drug Name |
[Hyp3, Thi5, D-NMF7] Bradykinin
|
||||
| Synonyms |
CHEMBL2371656
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C53H75N15O12S
|
||||
| Canonical SMILES |
CN([C@H](Cc1ccccc1)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)C(=O)[C@H](CO)NC(=O)[C@H](Cc3cccs3)NC(=O)CNC(=O)[C@@H]4CC(O)CN4C(=O)[C@@H]5CCCN5C(=O)[C@@H](N)CCCN=C(N)N
|
||||
| InChI |
InChI=1S/C53H75N15O12S/c1-66(41(25-32-14-6-3-7-15-32)47(75)64-37(24-31-12-4-2-5-13-31)44(72)63-36(51(79)80)18-9-21-60-53(57)58)49(77)39(30-69)65-45(73)38(27-34-16-11-23-81-34)62-43(71)28-61-46(74)42-26-33(70)29-68(42)50(78)40-19-10-22-67(40)48(76)35(54)17-8-20-59-52(55)56/h2-7,11-16,23,33,35-42,69-70H,8-10,17-22,24-30,54H2,1H3,(H,61,74)(H,62,71)(H,63,72)(H,64,75)(H,65,73)(H,79,80)(H4,55,56,59)(H4,57,58,60)/t33?,35-,36-,37-,38-,39-,40-,41+,42-/m0/s1
|
||||
| InChIKey |
FDNSGRXVGYVALV-OSPGXWTJSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | B1 bradykinin receptor | Target Info | [1587926] | ||
| B2 bradykinin receptor | Target Info | [1587926] | |||
| KEGG Pathway | Calcium signaling pathway | ||||
| Neuroactive ligand-receptor interaction | |||||
| Complement and coagulation cascades | |||||
| Inflammatory mediator regulation of TRP channels | |||||
| Regulation of actin cytoskeleton | |||||
| Pathways in cancerhsa04020:Calcium signaling pathway | |||||
| cGMP-PKG signaling pathway | |||||
| Sphingolipid signaling pathway | |||||
| Endocrine and other factor-regulated calcium reabsorption | |||||
| Chagas disease (American trypanosomiasis) | |||||
| Pathways in cancer | |||||
| Pathway Interaction Database | Direct p53 effectors | ||||
| Validated transcriptional targets of deltaNp63 isoforms | |||||
| WikiPathways | Complement and Coagulation Cascades | ||||
| ACE Inhibitor Pathway | |||||
| Regulation of Actin Cytoskeleton | |||||
| GPCRs, Class A Rhodopsin-like | |||||
| Vitamin D Receptor Pathway | |||||
| Gastrin-CREB signalling pathway via PKC and MAPK | |||||
| Peptide GPCRs | |||||
| GPCR ligand binding | |||||
| GPCR downstream signalingWP554:ACE Inhibitor Pathway | |||||
| Nifedipine Activity | |||||
| GPCR downstream signaling | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.